These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3186722)

  • 1. Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.
    Zanger UM; Hauri HP; Loeper J; Homberg JC; Meyer UA
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8256-60. PubMed ID: 3186722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human cytochrome P-450 is recognized by anti-liver/kidney microsome antibodies in autoimmune chronic hepatitis.
    Kiffel L; Loeper J; Homberg JC; Leroux JP
    Biochem Biophys Res Commun; 1989 Feb; 159(1):283-9. PubMed ID: 2466461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes.
    Yamamoto AM; Mura C; De Lemos-Chiarandini C; Krishnamoorthy R; Alvarez F
    Clin Exp Immunol; 1993 Jun; 92(3):381-90. PubMed ID: 7685669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-liver-kidney microsome antibody type 1 recognizes human cytochrome P450 db1.
    Gueguen M; Yamamoto AM; Bernard O; Alvarez F
    Biochem Biophys Res Commun; 1989 Mar; 159(2):542-7. PubMed ID: 2930529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis.
    Czaja AJ; Manns MP; Homburger HA
    Gastroenterology; 1992 Oct; 103(4):1290-5. PubMed ID: 1397887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sera of children with hepatitis C infection and anti-liver-kidney microsome-1 antibodies recognize different CYP2D6 epitopes than adults with LKM+/HCV+ sera.
    Herzog D; Yamamoto AM; Jara P; Maggiore G; Sarles J; Alvarez F
    J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):551-5. PubMed ID: 10554122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterization of the human cytochrome P-450 involved in polymorphic oxidation of propafenone.
    Kroemer HK; Mikus G; Kronbach T; Meyer UA; Eichelbaum M
    Clin Pharmacol Ther; 1989 Jan; 45(1):28-33. PubMed ID: 2910635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug.
    Beaune P; Dansette PM; Mansuy D; Kiffel L; Finck M; Amar C; Leroux JP; Homberg JC
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):551-5. PubMed ID: 3540968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human cytochrome P450s as autoantigens.
    Manns MP; Johnson EF
    Methods Enzymol; 1991; 206():210-20. PubMed ID: 1784210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1).
    Yamamoto AM; Cresteil D; Boniface O; Clerc FF; Alvarez F
    Eur J Immunol; 1993 May; 23(5):1105-11. PubMed ID: 7682958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic and immunologic similarities between monkey and human liver cytochrome P-450db1 (human cytochrome P-450 2D6).
    Otton SV; Tyndale RF; Wu D; Inaba T; Kalow W; Sellers EM
    Drug Metab Dispos; 1992; 20(1):1-5. PubMed ID: 1346982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily.
    Gueguen M; Meunier-Rotival M; Bernard O; Alvarez F
    J Exp Med; 1988 Aug; 168(2):801-6. PubMed ID: 2842431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
    Meyer UA; Gut J; Kronbach T; Skoda C; Meier UT; Catin T; Dayer P
    Xenobiotica; 1986 May; 16(5):449-64. PubMed ID: 2874666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to liver/kidney microsome1 in chronic active hepatitis recognize specific forms of hepatic cytochrome P-450.
    Waxman DJ; Lapenson DP; Krishnan M; Bernard O; Kreibich G; Alvarez F
    Gastroenterology; 1988 Nov; 95(5):1326-31. PubMed ID: 3049217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.
    Manns MP; Johnson EF; Griffin KJ; Tan EM; Sullivan KF
    J Clin Invest; 1989 Mar; 83(3):1066-72. PubMed ID: 2466049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with type II autoimmune hepatitis express functionally intact cytochrome P-450 db1 that is inhibited by LKM-1 autoantibodies in vitro but not in vivo.
    Manns M; Zanger U; Gerken G; Sullivan KF; Meyer zum Büschenfelde KH; Meyer UA; Eichelbaum M
    Hepatology; 1990 Jul; 12(1):127-32. PubMed ID: 2373473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-liver-kidney microsome antibody is a marker for the rat hepatocyte endoplasmic reticulum.
    De Lemos-Chiarandini C; Alvarez F; Bernard O; Homberg JC; Kreibich G
    Hepatology; 1987; 7(3):468-75. PubMed ID: 3552922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats.
    Suzuki T; Narimatsu S; Fujita S; Masubuchi Y; Umeda S; Imaoka S; Funae Y
    Drug Metab Dispos; 1992; 20(3):367-73. PubMed ID: 1355709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.
    Bourdi M; Larrey D; Nataf J; Bernuau J; Pessayre D; Iwasaki M; Guengerich FP; Beaune PH
    J Clin Invest; 1990 Jun; 85(6):1967-73. PubMed ID: 2347920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.